Abstract:Deoxyribonucleic acid (DNA) epigenetic modification has been linked to specific sequences of CpG islands and plays roles in the progression of lung cancer. In this study, it was found that peroxiredoxin-5 (PRDX5) was highly expressed in non-small cell lung cancer (NSCLC) tissues; however, its specific regulatory mechanisms and functions in NSCLC remain unknown. The present study therefore explored the regulatory mechanism of PRDX5 under conditions of oxidative stress (OS) in NSCLC. The results revealed that 79 of 121 NSCLC patients exhibited demethylation in the PRDX5 promoter region, which was related to the tumor, node and metastasis (TNM) stage (P=0.027). PRDX5 messenger ribonucleic acid (mRNA) expression positively correlated with the demethylation status of the promoter region. The results of bisulfite sequencing polymerase chain reaction (BSP) revealed lower demethylation frequencies in H1299 cells treated with 0 mu M H2O2, but maximum demethylation following treatment with 100 mu M H2O2. Using chromatin immunoprecipitation (ChIP) and luciferase detection assays, the effective binding of STAT3 to the transcriptional binding sites of the PRDX5 promoter region was confirmed (2 sites confirmed: Site 1, -444 to -434 bp; and site 4, -1,417 to -1,407 bp). STAT3 knockdown significantly decreased the protein expression of PRDX5, while the overexpression of STAT3 significantly increased the protein levels of PRDX5. When PRDX5 was overexpressed in lung cancer cells under conditions of OS, the levels of the epithelial-mesenchymal transition (EMT) biomarkers, E-cadherin and vimentin, were significantly decreased and increased, respectively. By contrast, PRDX5 knockdown resulted in significantly increased E-cadherin and decreased vimentin protein expression levels. Ultimately, when PRDX5-small interfering RNA (siRNA) or pcDNA3.1-PRDX5expression vector were constructed and transfected into H1299 cells pre-treated with 100 mu M H2O2, the nuclear factor (erythroid-derived 2)-like 2 (Nrf2) signaling pathway was inhibited or activated. All these results suggested that the reactive oxygen species (ROS)-mediated hypomethylation of PRDX5 enhanced STAT3 binding affinity with the promoter region, and resulted in the promotion of cell migration and invasion, as well as in the activation of the Nrf2 signaling pathway in NSCLC. The demethylation status of the PRDX5 promoter may thus be used as an epigenetic biomarker in NSCLC. STAT3/PRDX5 signaling may also prove to be a potential strategy for the treatment of this type of cancer.

S-nitrosylation of the Peroxiredoxin-2 Promotes S-nitrosoglutathione-mediated Lung Cancer Cells Apoptosis Via AMPK-SIRT1 Pathway

Cullin-5 Neddylation-Mediated NOXA Degradation is Enhanced by PRDX1 Oligomers in Colorectal Cancer

Peroxiredoxin-2 Nitrosylation Facilitates Cardiomyogenesis of Mouse Embryonic Stem Cells Via XBP-1s/PI3K Pathway.

Silencing of PRDX2 Inhibits the Proliferation and Invasion of Non-Small Cell Lung Cancer Cells

SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing Agents.

Peroxiredoxin 1 regulates crosstalk between pyroptosis and autophagy in oral squamous cell carcinoma leading to a potential pro-survival

Redox regulation of metabolic and signaling pathways by thioredoxin and glutaredoxin in NOS-3 overexpressing hepatoblastoma cells

PRDX5 As a Novel Binding Partner in Nrf2-mediated NSCLC Progression under Oxidative Stress.

The Emerging Roles of Nitric Oxide in Ferroptosis and Pyroptosis of Tumor Cells.

Small Changes Huge Impact: the Role of Thioredoxin 1 in the Regulation of Apoptosis by S-nitrosylation.

Suppression of VEGFD expression by S-nitrosylation promotes the development of lung adenocarcinoma

Peroxiredoxin 2 is Essential for Maintaining Cancer Stem Cell-Like Phenotype Through Activation of Hedgehog Signaling Pathway in Colon Cancer

Ros-Mediated Hypomethylation Of Prdx5 Promotes Stat3 Binding And Activates The Nrf2 Signaling Pathway In Nsclc

Peroxiredoxin V Silencing Elevates Susceptibility to Doxorubicin-induced Cell Apoptosis via ROS-dependent Mitochondrial Dysfunction in AGS Gastric Cancer Cells

Prdx2 Upregulation Promotes the Growth and Survival of Gastric Cancer Cells.

Peroxiredoxin 1 modulates oxidative stress resistance and cell apoptosis through stemness in liver cancer under non-thermal plasma treatment

New insights into the roles of peroxiredoxins in cancer

S-nitrosylation of ERK Inhibits ERK Phosphorylation and Induces Apoptosis

S-Nitrosylation Targets GSNO Reductase for Selective Autophagy during Hypoxia Responses in Plants.

Extensive protein S -nitrosylation associated with human pancreatic ductal adenocarcinoma pathogenesis

Reactive Oxygen and Nitrogen Species-Induced Protein Modifications: Implication in Carcinogenesis and Anticancer Therapy.